Garrett Vygantas

Dr. Garrett Vygantas is the Founding Managing Partner at Riverine Ventures, a early stage Life Science and Healthcare focused Venture Capital firm. Previously he was a Managing Director at OSF Healthcare Ventures and served on the Investment Committee. Prior to Riverine, Garrett was Chief Business Officer at Corsair Pharma, a biotech company developing innovative therapeutics to treat Pulmonary Hypertension. As an entrepreneur, Garrett co-founded TherOptix, an ocular therapeutics company and Mitre Medical, a structural heart disease medtech. He was a Partner at Jump Capital where he led the firm's healthcare investments. Prior to Jump, Garrett founded NewBridge Pharmaceuticals and served as President & CEO as EIR on the Burrill & Co Venture Capital Group. Earlier in his career, Garrett helped launch Lucentis, a breakthrough therapy for wet age related macular degeneration developed by Genentech, member of the Roche Group. Garrett previously worked with the Health Care Investment Banking group at Cowen and in Business Development at EntreMed. Garrett was a co-instructor at UCSF’s Center for BioEntrepreneurship’s “Idea to IPO” course and has advised in the formation of numerous biotech start-ups. Garrett completed his Transitional Residency at the University of Pennsylvania and holds MD & MBA degrees from Georgetown University as well as a BS in biochemistry from Boston College. He is a Kauffman Fellow.